Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Rapid and sensitive detection of drugs of abuse in sweat by multiplexed capillary based immuno-biosensors.

Xue W, Tan X, Khaing Oo MK, Kulkarni G, Ilgen MA, Fan X. Rapid and sensitive detection of drugs of abuse in sweat by multiplexed capillary based immuno-biosensors. The Analyst. 2020 Feb 17; 145(4):1346-1354.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions


Abstract:

Rapid and sensitive detection of drugs of abuse plays an important role in monitoring of drug use and treatment compliance. Sweat based drug analysis shows great advantages due to its non-invasive nature. However, most of the related methods developed to date are qualitative, slow, or costly, which significantly hinders their application in field use. Here we report rapid, sensitive, quantitative detection of drugs of abuse in sweat based on capillary arrays combined with competitive enzyme-linked immunosorbent assay. Using four common drugs of abuse, methadone, methamphetamine, amphetamine, and tetrahydrocannabinol, spiked in artificial sweat as a model system, we demonstrate rapid, quantitative, and multiplexed detection of the four drugs in ~16 minutes with a low sweat volume (~4 µL per analyte) and a large dynamic range (methadone: 0.0016 ng mL-1-1 ng mL-1; METH: 0.016 ng mL-1-25 ng mL-1; amphetamine: 0.005 ng mL-1-10 ng mL-1; THC: 0.02 ng mL-1-1000 ng mL-1). In addition, we show that the detection range can be tuned for different applications by adjusting the competitors'' concentrations. Our work paves a way to develop an autonomous, portable, and cost-effective device for hospital testing, workplace drug-use screening, roadside testing, and patient monitoring in drug rehabilitation centers.




Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.